Cargando…
Platelet Serotonin Concentration Is Associated with Illness Duration in Schizophrenia and Chronological Age in Depression
OBJECTIVE: Impaired serotonergic neurotransmission has been implicated in the pathogenesis of depression and schizophrenia. Blood platelets have been used for years as a peripheral model of neuronal serotonin dynamics. The objective was to investigate platelet count and serotonin concentration in pa...
Autores principales: | Peitl, Vjekoslav, Getaldić-Švarc, Biserka, Karlović, Dalibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324732/ https://www.ncbi.nlm.nih.gov/pubmed/32492767 http://dx.doi.org/10.30773/pi.2020.0033 |
Ejemplares similares
-
S115. SYMPTOM DOMAINS IN SCHIZOPHRENIA AND GENE POLYMORPHISMS
por: Peitl, Vjekoslav, et al.
Publicado: (2018) -
The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real-world Clinical Setting
por: Peitl, Vjekoslav, et al.
Publicado: (2022) -
Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
por: Jazvinšćak Jembrek, Maja, et al.
Publicado: (2023) -
Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
por: Peitl, Vjekoslav, et al.
Publicado: (2023) -
Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19
por: Nadalin, Sergej, et al.
Publicado: (2021)